Logo Join | Forum| Help | Bookmark | Login
Submit New Story
Home Stories Groups People Marketplace | FREE Benefits
The US Food and Drug Administration (FDA) Oncology Drug Advisory Committee is to meet tomorrow, Wednesday 5th December, to decide whether to recommend the agency approve Genentech Inc's cancer drug Avastin as a treatment for breast cancer. The FDA does not have to follow the advice of its advisory panels, which include practising physicians, but it usually does.

The panel will review two papers during the meeting. One paper is the drug company's application for approval supported by evidence from clinical trials. The other paper is a review of the clinical evidence by FDA staff.

Genentech want the FDA to extend its current approval to say that: "Avastin, in combination with paclitaxel, is indicated for the treatment of patients who have not received chemotherapy for their locally recurrent or metastatic breast cancer."

The drug company's papers show evidence of significantly improved progression free survival rates (PFS) among clinical trial participants. In a study involving some 700 patients, the median PFS went up by 5.5 months. PFS measures how long before the cancer gets worse.

The FDA staff's review acknowledges the improved PFS rates from the Genentech clinical trials, but said this must be weighed against no significant change in overall survival, and more serious side effects, including death.

Avastin (bevacizumab) is currently approved by the FDA for treating patients with colon and non-small cell lung cancer with other drugs, although some doctors have started using it "off label" to treat breast cancer.

Avastin is not a chemotherapy drug, it's a monoclonal antibody that starves cancer tumours by blocking the growth of blood vessels to the tumours. The disadvantage of chemotherapy drugs is that they can also kill healthy cells.

http://www.medicalnewstoday.com/articles/90576.php
Tags: breast, medication
Posted By: Mechka 1 Year, 2 Weeks, 1 day, 22 hours, 31 minutes ago
All Votes: 2
Bookmark
Comments (0) | Who voted on this story (2) | Email this story
 

UnitedProject.org Inc. (c) 2006-2008 All content published on UnitedProject.org is provided for informational purposes only and is not meant to substitute for the advice, diagnosis or treatment provided by your physician or other healthcare professionals. If you think you are experiencing a medical problem or an emergency please contact your physician, local emergency room or call 911. Healthcare benefits and discounts are not insurance and not intended as a substitute for health insurance. Except when other source is cited, all content posted by members is licensed under Creative Commons Public Domain License.

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.


Site last updated 11/19/08 - loaded in 0.0112 seconds